製品の概要

  • 製品名

    L-DOPA, Dopamine (ab120565) precursor
  • 製品の詳細

    Dopamine (ab120565) precursor
  • 別名

    • Levodopa
  • 生理活性の詳細

    Dopamine (ab120565) precursor. Blood-brain barrier permeable. Increases dopamine levels in Parkinson's disease models to display anti-Parkinson's disease properties.
  • 精製度

    > 99%
  • CAS 番号

    59-92-7
  • 構造式

    Chemical Structure

製品の特性

参考文献

This product has been referenced in:

  • Ahmed MR  et al. Lentiviral overexpression of GRK6 alleviates L-dopa-induced dyskinesia in experimental Parkinson's disease. Sci Transl Med 2:28ra28 (2010). Read more (PubMed: 20410529) »
  • Pisani A & Shen J Levodopa-induced dyskinesia and striatal signaling pathways. Proc Natl Acad Sci U S A 106:2973-4 (2009). Read more (PubMed: 19251671) »
  • Muñoz A  et al. Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia. Brain 131:3380-94 (2008). Read more (PubMed: 18952677) »
See all 4 Publications for this product

レビューと Q&A

There are currently no Customer reviews or Questions for ab120573.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES, NOT FOR USE IN HUMANS"
For licensing inquiries, please contact partnerships@abcam.com

登録